Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRADIMED CORP Director's Dealing 2021

Dec 10, 2021

32324_dirs_2021-12-09_a43d5545-cdfd-44a9-ac9d-6c31a9670e15.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2021-12-07

Reporting Person: ALLEN MONTY K (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-07 Common Stock M 2185 Acquired 18963 Direct
2021-12-07 Common Stock M 2037 Acquired 21000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-12-07 Restricted Stock Units $ A 2071 Acquired Common Stock (2071) Direct
2021-12-07 Restricted Stock Units $ M 2185 Disposed Common Stock (2185) Direct
2021-12-07 Restricted Stock Units $ M 2037 Disposed Common Stock (2037) Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F3: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F4: On December 7, 2019, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F5: On December 7, 2020, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.